← Open Payments lookup

GLORIA FOSU: Open Payments

NPI 1003560566 · LAUREL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$525 in 22 payments from 6 companies in 2025. Trend: 2023 $445 · 2024 $139 · 2025 $525

Food & beverage: $525
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$247
ABBVIE INC.8$151
Otsuka America Pharmaceutical, Inc.2$45
Janssen Pharmaceuticals, Inc3$44
E.R. Squibb & Sons, L.L.C.1$23
Lundbeck LLC1$15

Products named: CAPLYTA, VRAYLAR, INVEGA SUSTENNA, ABILIFY ASIMTUFII, COBENFY, ABILIFY MAINTENA, REXULTI, SPRAVATO.

Industry payments across MD — which companies pay providers there.